Holen Sie sich die Stockscreener-App
17.33
1.76%
-0.31
Handel nachbörslich:
18.30
0.97
+5.60%
Schlusskurs vom Vortag:
$17.64
Offen:
$17.43
24-Stunden-Volumen:
757.09K
Relative Volume:
0.92
Marktkapitalisierung:
$1.92B
Einnahmen:
$418.33M
Nettoeinkommen (Verlust:
$-252.07M
KGV:
-7.2208
EPS:
-2.4
Netto-Cashflow:
$-238.84M
1W Leistung:
-5.46%
1M Leistung:
-11.22%
6M Leistung:
-51.17%
1J Leistung:
-30.15%
1-Tages-Spanne:
$17.24
$17.58
1-Wochen-Bereich:
$17.18
$17.97
52-Wochen-Spanne:
$16.82
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Firmenname
Zai Lab Limited Adr
Sektor
Branche
Telefon
862161632588
Adresse
899 HALEI ROAD, SHANGHAI
Vergleichen Sie ZLAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
17.33 | 1.95B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Fortgesetzt | Jefferies | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-21 | Eingeleitet | Macquarie | Outperform |
| 2021-10-12 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-04-15 | Eingeleitet | Guggenheim | Buy |
| 2019-07-12 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-05 | Eingeleitet | Macquarie | Outperform |
| 2019-01-29 | Eingeleitet | Credit Suisse | Outperform |
| 2018-11-21 | Eingeleitet | Jefferies | Buy |
| 2018-06-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Eingeleitet | JP Morgan | Neutral |
| 2017-10-16 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten
The Truth About Zai Lab Ltd (ADR): Is This Sleeper Stock About To Explode Or Nah? - AD HOC NEWS
Zai Lab (NASDAQ:ZLAB) Insider Rafael Amado Sells 10,787 Shares - Defense World
The Truth About Zai Lab Ltd (ADR): Is This Sleeper Stock About To Explode Or Fade? - AD HOC NEWS
EBITDA per share of Zai Lab Ltd. Sponsored ADR – MUN:1ZL - TradingView — Track All Markets
Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025 - ts2.tech
Zai Lab (NASDAQ:ZLAB) Shares Gap UpTime to Buy? - MarketBeat
FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug - Sahm
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia - Business Wire
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
CapEx per share of Zai Lab Ltd. Sponsored ADR – MUN:1ZL - TradingView — Track All Markets
How Investors May Respond To Zai Lab (ZLAB) Advancing ZL-1503 Into Global Phase 1/1b Atopic Dermatitis Trial - Sahm
Zai Lab (NASDAQ:ZLAB) Hits New 12-Month LowTime to Sell? - MarketBeat
How Investors Are Reacting To Zai Lab (ZLAB) Advancing ZL-1503 And Securing Key NRDL Renewals - Sahm
Zai Lab (NASDAQ:ZLAB) Hits New 1-Year LowShould You Sell? - MarketBeat
Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis - Business Wire
Zai Lab Announces Updates to China’s National Reimbursement Drug List - Business Wire
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - MSN
What Zai Lab (ZLAB)'s Q3 Results and Reaffirmed 2025 Guidance Mean for Shareholders - Sahm
Zai Lab (ZLAB) Remains a Buy Amid Strong Commercial and Pipeline Momentum - Finviz
Mitchells & Butlers (LON:MAB) Shares Up 7.2% – Should You Buy? - Defense World
Analysts Set Aardvark Therapeutics, Inc. (NASDAQ:AARD) PT at $30.63 - Defense World
Hamilton Insurance Group, Ltd. (NYSE:HG) Receives $28.63 Average Target Price from Brokerages - Defense World
Brokerages Set Circle Internet Group, Inc. (NYSE:CRCL) Price Target at $150.33 - Defense World
Analyzing YY Group (NASDAQ:YYGH) and Cintas (NASDAQ:CTAS) - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zai Lab (NASDAQ:ZLAB) Sees Strong Trading VolumeHere's Why - MarketBeat
Boston Partners Sells 690,421 Shares of Synchrony Financial $SYF - Defense World
Boston Partners Purchases 1,111 Shares of Wells Fargo & Company $WFC - Defense World
CocaCola Company (The) $KO Shares Purchased by Boston Partners - Defense World
Boston Partners Reduces Position in The Travelers Companies, Inc. $TRV - Defense World
Boston Partners Buys 525,214 Shares of Trimble Inc. $TRMB - Defense World
Zai Lab Ltd. Sponsored ADR (ZLAB) Stock Price Today | Live Chart & News - Traders Union
Can Zai Lab Limited (1ZLB) stock test all time highsQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com
EBITDA per share of Zai Lab Ltd. Sponsored ADR – SWB:1ZL - TradingView
UBS Lists CN Stocks w/ Highest Potential FY26 Earnings Upside (Table) - AASTOCKS.com
Zai Lab Ltd (1ZLB) Gets a Buy from UBS - The Globe and Mail
Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st
There is no doubt that Zai Lab Limited ADR (ZLAB) ticks all the boxes. - Setenews
Check Out Companhia Siderurgica Nacional ADR (SID)’s Trade Data Rather Than the Analysts’ Views - Setenews
symbol__ Stock Quote Price and Forecast - CNN
Stocks of Super Group (SGHC) Limited (SGHC) are poised to climb above their peers - setenews.com
Zai Lab (NASDAQ:ZLAB) Sets New 1-Year Low After Earnings Miss - Defense World
Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est - GuruFocus
Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive - simplywall.st
Why Zai Lab Limited (1ZLB) stock appeals to dividend investors2025 Bull vs Bear & Real-Time Buy Zone Alerts - Fundação Cultural do Pará
Brokerages Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Price Target at $56.35 - Defense World
Keeping an Eye on Nine Energy Service Inc (NINE) After Insider Trading Activity - knoxdaily.com
ZLAB: Goldman Sachs Removes Zai Lab from APAC Conviction List - GuruFocus
Zai Lab (NasdaqGM:ZLAB): Evaluating Valuation Following Promising Trial Results and Phase 3 Progress - Sahm
Finanzdaten der Zai Lab Limited Adr-Aktie (ZLAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):